Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.

纳米生物技术是一个很有前途的研究领域，已被用于开发对抗寨卡病毒 (ZIKV) 的技术。本研究旨在使用 Orbit Intelligence 软件分析与在对抗 ZIKV 的策略中使用纳米生物技术相关的专利场景。结果表明，2015 年至 2019 年间专利申请数量有所增长。 Modernatx、麻省理工学院和哈佛大学拥有 38% 的针对 ZIKV 开发的技术。EPO、WIPO 和美国收到了 47% 的专利保护申请，这些申请是由公司在药理学和生物技术领域的技术支持下开发的。发现的专利中约有 42% 属于诊断和预防领域，这些专利是在纳米粒子的帮助下设计的，用作疫苗和快速测试的传递系统。